Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IM Olanzapine vs Haloperidol in Agitated Schizophrenia
NCT00485901Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in schizophrenia, sponsored by Eli Lilly and Company. Started Jul 2004; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00485901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485901.